deCODE genetics (Amgen) — Iceland Population Sequencing
organizationBiotech & Transhumanism
One company sequenced the DNA of nearly an entire country and tied it to their medical and family records.
Who they are
deCODE genetics, an Iceland-based company bought by the drug giant Amgen in 2012 for $415 million.
What they do
The engine treats it as the gold-standard population DNA dataset.
How it works
It sequenced or reconstructed the genomes of most of Iceland's population and linked them to deep medical and genealogical records, per Gudbjartsson et al. in Nature Genetics (2015).
Why it matters
That combination is the mathematical foundation for accurately predicting traits and disease risk from a person's genes.
The engine's record — word for word
**In plain terms:** the gold-standard population genome set — deCODE (bought by Amgen 2012, $415M) sequenced/imputed the genomes of most of Iceland, correlated to deep medical+genealogical records. The mathematical basis for high-fidelity polygenic prediction. Source: P3; Amgen 2012; Gudbjartsson et al. Nat Genet 2015.
Follow the trail
Walk this on the live map →